150 related articles for article (PubMed ID: 1466618)
1. Effects of recombinant human growth hormone in patients with severe sepsis.
Voerman HJ; van Schijndel RJ; Groeneveld AB; de Boer H; Nauta JP; van der Veen EA; Thijs LG
Ann Surg; 1992 Dec; 216(6):648-55. PubMed ID: 1466618
[TBL] [Abstract][Full Text] [Related]
2. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial.
Voerman BJ; Strack van Schijndel RJ; Groeneveld AB; de Boer H; Nauta JP; Thijs LG
Crit Care Med; 1995 Apr; 23(4):665-73. PubMed ID: 7712756
[TBL] [Abstract][Full Text] [Related]
3. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support.
Voerman BJ; Strack van Schijndel RJ; de Boer H; Groeneveld AB; Nauta JP; van der Veen EA; Thijs LG
J Crit Care; 1994 Sep; 9(3):143-50. PubMed ID: 7981777
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition.
Ziegler TR; Young LS; Manson JM; Wilmore DW
Ann Surg; 1988 Jul; 208(1):6-16. PubMed ID: 3133995
[TBL] [Abstract][Full Text] [Related]
5. Use of human growth hormone combined with nutritional support in a critical care unit.
Ziegler TR; Young LS; Ferrari-Baliviera E; Demling RH; Wilmore DW
JPEN J Parenter Enteral Nutr; 1990; 14(6):574-81. PubMed ID: 2273531
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition.
Mjaaland M; Unneberg K; Larsson J; Nilsson L; Revhaug A
Ann Surg; 1993 Apr; 217(4):413-22. PubMed ID: 8466313
[TBL] [Abstract][Full Text] [Related]
7. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial.
Sevette A; Smith RC; Aslani A; Kee AJ; Hansen R; Barratt SM; Baxter RC
Clin Nutr; 2005 Dec; 24(6):943-55. PubMed ID: 16083996
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study.
Ziegler TR; Rombeau JL; Young LS; Fong Y; Marano M; Lowry SF; Wilmore DW
J Clin Endocrinol Metab; 1992 Apr; 74(4):865-73. PubMed ID: 1548352
[TBL] [Abstract][Full Text] [Related]
9. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients.
Ziegler TR; Leader I
Semin Respir Infect; 1994 Dec; 9(4):240-7. PubMed ID: 7886321
[TBL] [Abstract][Full Text] [Related]
11. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
12. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
Snyder DK; Clemmons DR; Underwood LE
J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone.
Giustina A; Bussi AR; Jacobello C; Wehrenberg WB
J Clin Endocrinol Metab; 1995 Jan; 80(1):122-9. PubMed ID: 7829600
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients.
Jeevanandam M; Ali MR; Holaday NJ; Petersen SR
JPEN J Parenter Enteral Nutr; 1995; 19(2):137-44. PubMed ID: 7609279
[TBL] [Abstract][Full Text] [Related]
15. [Effect of recombinant growth hormone on amino acids metabolism in blood and urine after major operation].
He G; Jiang Z; Yang N; Shu H; Wilmore DW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):192-6. PubMed ID: 10453490
[TBL] [Abstract][Full Text] [Related]
16. Time course and variability of the endocrine and metabolic response to severe sepsis.
Voerman HJ; Groeneveld AB; de Boer H; Strack van Schijndel RJ; Nauta JP; van der Veen EA; Thijs LG
Surgery; 1993 Nov; 114(5):951-9. PubMed ID: 8236020
[TBL] [Abstract][Full Text] [Related]
17. Systemic and splanchnic metabolic response to exogenous human growth hormone.
Dahn MS; Lange MP
Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone treatment after abdominal surgery decreased carbohydrate oxidation and increased fat oxidation in patients with total parenteral nutrition.
Mjaaland M; Unneberg K; Bjøro T; Revhaug A
Metabolism; 1993 Feb; 42(2):185-90. PubMed ID: 8474315
[TBL] [Abstract][Full Text] [Related]
19. Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation.
Duska F; Fric M; Waldauf P; Pazout J; Andel M; Mokrejs P; Tůma P; Pachl J
Crit Care Med; 2008 Jun; 36(6):1707-13. PubMed ID: 18496372
[TBL] [Abstract][Full Text] [Related]
20. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.
Lieberman SA; Butterfield GE; Harrison D; Hoffman AR
J Clin Endocrinol Metab; 1994 Feb; 78(2):404-10. PubMed ID: 7508949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
